2013
DOI: 10.1002/ddr.21092
|View full text |Cite
|
Sign up to set email alerts
|

Nutritional Targets for Modulation of the Microbiota in Obesity

Abstract: The gut microbiota is being increasingly appreciated by both clinical and research professionals as the human ancestral genome has undergone modification by the microbes that colonize the human body. The gut is now known to be a key metabolic organ that contains some 15 000 bacterial species that influence health and chronic diseases, the latter including obesity, type 2 diabetes, hepatic steatosis, and hypertension. Based on the potentially beneficial effects of nutrients, this review discusses how obesity di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 104 publications
(135 reference statements)
1
0
0
Order By: Relevance
“…Of note, the observed enrichment in ABC transporters and pathways associated to lipid metabolism in mice treated with the vehicle is consistent with human findings showing significant over-representation of these pathways in patients with atherosclerotic cardiovascular disease, cirrhosis, obesity, and type-2 diabetes [32]. Interestingly, GCE contributed further changes in gut microbiota, prompting enrichment of beneficial microbes, including Desulfovibrio , a sulfate-reducing bacterium that exerts anti-inflammatory effects [104] and that has been linked to liver detoxification [105], and Mogibacteriaceae , bacteria negatively associated with the risk of thrombosis [106]. These changes in gut microbiota composition were accompanied by enrichment in metabolic pathways, including sulfur metabolism, host glycan degradation, and antimicrobial peptide resistance, all of which are associated with healthy states in humans [32,107].…”
Section: Discussionsupporting
confidence: 74%
“…Of note, the observed enrichment in ABC transporters and pathways associated to lipid metabolism in mice treated with the vehicle is consistent with human findings showing significant over-representation of these pathways in patients with atherosclerotic cardiovascular disease, cirrhosis, obesity, and type-2 diabetes [32]. Interestingly, GCE contributed further changes in gut microbiota, prompting enrichment of beneficial microbes, including Desulfovibrio , a sulfate-reducing bacterium that exerts anti-inflammatory effects [104] and that has been linked to liver detoxification [105], and Mogibacteriaceae , bacteria negatively associated with the risk of thrombosis [106]. These changes in gut microbiota composition were accompanied by enrichment in metabolic pathways, including sulfur metabolism, host glycan degradation, and antimicrobial peptide resistance, all of which are associated with healthy states in humans [32,107].…”
Section: Discussionsupporting
confidence: 74%